These findings were recently published in eLife, from a phase II clinical trial led by Professor Guy Thwaites
With funding from the Wellcome Trust, OUCRU researchers investigated whether the addition of aspirin at low (81mg/day) or high (1000mg/day) dose, or placebo, to the first 60 days of current standard TB meningitis treatment (anti-TB drugs and steroids) was safe and reduced new strokes or death from this severe disease.
Professor Thwaites was recently interviewed about this work for the eLife podcast, and you can listen to the interview on eLife podcast (at 14:45 on the clock)
eLife have also published an insight article, which discusses this study and its results